Editorial: adalimumab or infliximab as monotherapy, or in combination with an immunomodulator, in the treatment of Crohn's disease
Volume: 45, Issue: 1, Pages: 178 - 179
Published: Dec 2, 2016
Abstract
Linked Content This article is linked to Cosnes et al paper. To view this article visit https://doi.org/10.1111/apt.13808...
Paper Details
Title
Editorial: adalimumab or infliximab as monotherapy, or in combination with an immunomodulator, in the treatment of Crohn's disease
Published Date
Dec 2, 2016
Volume
45
Issue
1
Pages
178 - 179
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History